BriaCell Therapeutics Corp. (BCT.TO)
5.14
+0.32
(+6.64%)
CAD |
TSX |
Aug 25, 15:59
BriaCell Therapeutics EPS Diluted (Quarterly) : -1.354 for April 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -1.354 |
| January 31, 2026 | -3.575 |
| October 31, 2025 | -6.038 |
| July 31, 2025 | -5.902 |
| April 30, 2025 | -23.32 |
| January 31, 2025 | -33.10 |
| October 31, 2024 | -44.62 |
| July 31, 2024 | -0.0922 |
| April 30, 2024 | 0.1457 |
| January 31, 2024 | -0.9555 |
| October 31, 2023 | -0.6742 |
| July 31, 2023 | -0.202 |
| April 30, 2023 | -0.4274 |
| January 31, 2023 | -1.032 |
| October 31, 2022 | -0.0949 |
| April 30, 2022 | -123.93 |
| January 31, 2022 | 115.21 |
| October 31, 2021 | -340.62 |
| April 30, 2021 | 117.39 |
| January 31, 2021 | -0.3755 |
| October 31, 2020 | -0.6284 |
| July 31, 2020 | -0.9634 |
| April 30, 2020 | -0.9705 |
| January 31, 2020 | -2.608 |
| October 31, 2019 | -2.415 |
| Date | Value |
|---|---|
| July 31, 2019 | -2.589 |
| April 30, 2019 | -116796.2 |
| January 31, 2019 | -2.913 |
| October 31, 2018 | -1.959 |
| July 31, 2018 | -4.047 |
| April 30, 2018 | -3.00 |
| January 31, 2018 | -3.00 |
| October 31, 2017 | -3.00 |
| July 31, 2017 | -3.00 |
| April 30, 2017 | -514.80 |
| January 31, 2017 | -1.242 |
| October 31, 2016 | -1.428 |
| July 31, 2016 | -1.20 |
| April 30, 2016 | -1.506 |
| January 31, 2016 | -3.00 |
| October 31, 2015 | -1.428 |
| July 31, 2015 | -1.317 |
| April 30, 2015 | -3.00 |
| January 31, 2015 | -12.00 |
| October 31, 2014 | -2.223 |
| July 31, 2014 | -136.50 |
| April 30, 2014 | -9.75 |
| January 31, 2014 | -1.502 |
| October 31, 2013 | -2.701 |
| July 31, 2013 | -1.765 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.0039 |
| Quest PharmaTech, Inc. | 0.0201 |
| Vaxil Bio Ltd. | -0.0269 |
| Waverley Pharma, Inc. | -0.0031 |
| Goldcoast Resource Corp. | -0.0725 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.920M |
| Total Expenses (Quarterly) | 9.820M |
| Enterprise Value | 3.025M |
| Earnings Yield | -328.2% |
| Normalized Earnings Yield | -334.97 |